Effect of aripiprazole once-monthly 400mg (AOM400) on hospitalisation prevention and use of healthcare resources in schizophrenia patients, a study based on real clinical practice on schizophrenia: AMBITION Study

INTRODUCTION: Schizophrenia is a large and increasing burden for patients from early stages of the disease. Long-acting injectable antipsychotics (LAIs), like aripiprazole once-monthly 400 mg (AOM400), have demonstrated an improvement in treatment adherence compared to oral formulations, with a cons...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchez-Gistau, V., Moreno, M. J., Gómez-Lus, S., Sicras Mainar, A., Crespo-Facorro, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434424/
http://dx.doi.org/10.1192/j.eurpsy.2023.1052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434424/
http://dx.doi.org/10.1192/j.eurpsy.2023.1052

Ejemplares similares